Short Interest in Exicure, Inc. (NASDAQ:XCUR) Decreases By 34.8%

Exicure, Inc. (NASDAQ:XCUR) was the target of a large decline in short interest in December. As of December 15th, there was short interest totalling 61,200 shares, a decline of 34.8% from the November 30th total of 93,900 shares. Based on an average trading volume of 725,400 shares, the short-interest ratio is currently 0.1 days. Approximately 5.6% of the shares of the stock are short sold.

Exicure Trading Up 1.9 %

XCUR stock opened at $17.58 on Monday. The business’s 50 day moving average is $12.57 and its 200-day moving average is $5.25. Exicure has a 1-year low of $1.44 and a 1-year high of $36.00. The firm has a market cap of $45.81 million, a P/E ratio of -8.49 and a beta of 3.66.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.